ArticleIndian journal of dermatology

Topical Tofacitinib for Atopic Dermatitis - Outcomes from Randomized Phase 3 Clinical Trial: First Approval.

Alok R Chaturvedi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.